Tang v. Eastern Virginia Medical School

District Court, E.D. Virginia·Decided November 14, 2022·No. 2:20-cv-00575·Unknown

Opinion

FINO RT HTHE EU ENAITSETDE RSNTA DTIESTS RDIICSTT ROIFC VT ICROGUINRITA Norfolk Division

AMY H. TANG, ) Plaintiff, ) ) v. ) Civil Action No. 2:20CV575 (RCY) ) EASTERN VIRGINIA ) MEDICAL SCHOOL, ) Defendant. ) )

MEMORANDUM OPINION

This matter is before the Court on Plaintiff’s Motion to Reconsider (ECF No. 56). The Motion to Reconsider has been fully briefed, and the Court dispenses with oral argument because the facts and legal contentions are fully developed, and argument would not aid the Court in its decisional process. E.D. Va. Loc. Civ. R. 7(J). For the reasons stated below, the Court will deny Plaintiff’s Motion to Reconsider (ECF No. 56). I. BACKGROUND This action presents a lengthy and complex factual and procedural history that has been previously produced in the Court’s opinions.1 Only the facts pertinent to this specific motion are produced herein. Dr. Amy Tang (“Plaintiff” or “Dr. Tang”) was an Assistant Professor in the Department of Microbiology and Molecular Cell Biology at Eastern Virginia Medical School (“Defendant” or “EVMS”). Tang, 2022 WL 981942, at *1 (E.D. Va. Mar. 30, 2022). Dr. Tang attempted to seek a patent that would cover a chemical called Ethylenediaminetetraacetic Acid (“EDTA”). Id. Dr. Tang brought claims against EVMS under the Defend Trade Secrets Act (“DTSA”) and the Virginia Uniform Trade Secrets Act (“VUTSA”), arguing that she had an

1 The Court incorporates by reference the facts set forth in the Memorandum Opinion issued on March 30, 2022. Tang v. E. Virginia Med. Sch., No. 2:20CV575, 2022 WL 981942, at *1-3 (E.D. Va. Mar. 30, 2022). ownership in the trade secrets and EVMS misappropriated her trade secret, EDTA, from October 2018 to August 2019. Id. at *9. The Court granted EVMS summary judgment and held that Plaintiff’s Employment Agreement precludes her from asserting a claim of misappropriation of the trade secret against EVMS. Id. at *10. Specifically, the Court found that “Plaintiff's Employment Agreement and Participation/Confidential Non-Disclosure Agreement clearly assign “every trade secret, idea, know how, discovery, or invention (together hereinafter referred to as ‘Invention’)” to EVMS.” Id. Further the Court noted that when Dr. Tang was “asked why she submitted the EDTA invention disclosure, [she] answered, ‘to protect EVMS IP.’” Id. Thus, because “Plaintiff [could not] establish ownership or lawful possession of a trade secret as required for her claim of misappropriation” and “EVMS acquired the trade secret through express consent

via Plaintiff’s Employment Agreement and Participation/Confidential Non-Disclosure Agreement” the Court ruled that Plaintiff could not establish misappropriation and Defendant was entitled to summary judgment. Id. at *10-11. Email exchanges are at the center of the dispute. On October 13, 2018, Plaintiff sent an email to Paul DiMarco, EVMS’s Director of Technology Transfer, submitting her invention disclosure for patentability review. Id. at * 1. On October 16, 2018, Mr. DiMarco sent Plaintiff's invention disclosure to outside counsel to determine whether Plaintiff's purported invention was patentable. Id. Then, on November 25, 2019, EVMS officially assigned the disclosed invention to Plaintiff via the Invention Assignment Agreement. Id. Now, Plaintiff attempts to introduce a

“new” piece of evidence. Specifically, Plaintiff puts forward a November 26, 2018, email exchange between her and Mr. DiMarco, in which reads in part: Dr. Tang: . . . Could you please generate an official letter to return the patent right back to me at EVMS? Mr. DiMarco: We are not asserting our assignment. That takes place later in the application process if we decide to proceed with an application. There are official forms generated by the attorneys and submitted to the PTO when that takes place. You are therefore free to pursue patentability and commercial opportunities under your own efforts.

Dr. Tang:

. . . I need a similar EVMS Official Letter as the one that you generated for SIAH application so that I can pursue this independently myself.

Mr. DiMarco:

Okay Amy – will do . . .

(Exhibit 1, 1-3, ECF No. 57-1.) II. PROCEDURAL HISTORY Plaintiff filed her Complaint on November 18, 2020 (ECF No. 1). On January 20, 2021, Defendant filed a Motion to Dismiss (ECF No. 5) and an Answer and Affirmative Defenses (ECF No. 7). On February 3, 2021, Defendant filed an Amended Complaint (ECF No. 9) and a Brief in Opposition to Motion to Dismiss (ECF No. 10). On February 16, 2021, the Court denied the Motion to Dismiss (ECF No. 5) as moot because Plaintiff had filed an Amended Complaint. The Court directed the Defendant to file a response to Plaintiff’s Amended Complaint. On February 19, 2021, Defendant filed a Motion to Dismiss (ECF No. 13) and an Answer and Affirmative Defenses to the Amended Complaint (ECF No. 15). On July 7, 2021, Defendant filed a Motion for Summary Judgment and a Memorandum in Support (ECF Nos. 31, 32). On July 12, 2021, the Court granted Defendant’s Motion to Dismiss as to Counts One, Five, and Six, denied the Motion as to Counts Three, Four, Seven, Eight, Nine, Ten, and Eleven, and granted in part and denied in part as to Count Two (ECF Nos. 33, 34). On March 4, 2022, Plaintiff filed a Motion for Substitution of Counsel (ECF No. 45). On March 30, 2022, the Court granted Defendant’s Motion for Summary Judgment on all counts (ECF Nos. 46, 47). On April 14, 2022, the Court granted Plaintiff’s Motion for Substitution of Counsel, substituting in Joshua A. Harman, Esq., and the law firm of Merchant & Gould. (ECF No. 52). On April 27, 2022, the Plaintiff filed her Motion for Reconsideration (ECF No. 56), asking the Court’s to reconsider its grant of summary judgment for Defendant. On April 29, 2022, the Plaintiff filed her Notice of Appeal as to the Court’s orders on the Motion to Dismiss and the Motion for Summary Judgment. (ECF No. 58.) On May 5, 2022, Defendant filed its Response in Opposition to the Motion for Reconsideration (ECF No. 62), and on May 11, 2022, Plaintiff filed her Reply (ECF No. 64).

III. LEGAL STANDARD Rule 59(e) allows a party to ask a court to “alter or amend a judgment” no later than 28 days after the entry of such judgment. Fed. R. Civ. Proc. 59(e). The Fourth Circuit recognizes three grounds by which alteration of a previous judgment is permissible: “(1) to accommodate an intervening change in controlling law; (2) to account for new evidence not available at trial; or (3) to correct a clear error of law or prevent manifest injustice.” Pac. Ins. Co. v. Am. Nat. Fire Ins. Co., 148 F.3d 396, 403 (4th Cir. 1998). However, Rule 59(e) cannot be used “to raise arguments which could have been raised prior to the issuance of the judgment,” nor can it be used to advance “a case under a novel legal theory that the party had the ability to address in the first instance.” Id.

Relevant to the issue at hand, Rule 59(e) cannot be employed to “relitigate old matters, or to raise arguments or present evidence that could have been raised prior to the entry of judgment.” 11 Charles Alan Wright & Arthur R. Miller, Federal Practice and Procedure § 2810.1 (2d ed. 1995). If a party attempts to rely on “newly discovered evidence in its Rule 59(e) motion, the party ‘must produce a legitimate justification for not presenting the evidence during the earlier proceeding.’” Pac. Ins. Co., 148 F.3d at 403 (quoting Small v. Hunt, 98 F.2d 789, 798 (4th Cir. 1996)). “Reconsideration of a judgment after its entry is an extraordinary remedy which should be used sparingly.” Id. IV.

Free access — add to your briefcase to read the full text and ask questions with AI

Tang v. Eastern Virginia Medical School, (E.D. Va. 2022).

Tang v. Eastern Virginia Medical School (Tang v. Eastern Virginia Medical School) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related